{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:47:19Z","timestamp":1782175639399,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-50392-7","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:06:54Z","timestamp":1777320414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IRF9-dependent transcriptional regulation of SLC40A1 suppresses ferroptosis in dilated cardiomyopathy"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhi","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingzhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"1","key":"50392_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.62347\/AOSK8903","volume":"17","author":"H Zhang","year":"2025","unstructured":"Zhang, H., Guo, H., Han, F. & Zheng, Y. Regulatory mechanisms of m(6)A methylation in dilated cardiomyopathy. Am. J. Transl. Res. 17 (1), 47\u201359 (2025).","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"50392_CR2","doi-asserted-by":"publisher","first-page":"e30097","DOI":"10.1371\/journal.pone.0030097","volume":"7","author":"L An","year":"2012","unstructured":"An, L. et al. Involvement of autophagy in cardiac remodeling in transgenic mice with cardiac specific over-expression of human programmed cell death 5. PLoS One. 7 (1), e30097 (2012).","journal-title":"PLoS One"},{"issue":"1","key":"50392_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41598-024-83455-8","volume":"15","author":"H Yang","year":"2025","unstructured":"Yang, H. et al. Prognostic signature and therapeutic drug identification for dilated cardiomyopathy based on necroptosis via bioinformatics and experimental validation. Sci. Rep. 15 (1), 319 (2025).","journal-title":"Sci. Rep."},{"issue":"42","key":"50392_CR4","doi-asserted-by":"publisher","first-page":"e2323052121","DOI":"10.1073\/pnas.2323052121","volume":"121","author":"H Kalinoski","year":"2024","unstructured":"Kalinoski, H. et al. Injury-induced myosin-specific tissue-resident memory T cells drive immune checkpoint inhibitor myocarditis. Proc. Natl. Acad. Sci. U S A. 121 (42), e2323052121 (2024).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"50392_CR5","doi-asserted-by":"publisher","first-page":"16420","DOI":"10.1038\/s41598-023-41942-4","volume":"13","author":"AK Sharma","year":"2023","unstructured":"Sharma, A. K. et al. New drug discovery of cardiac anti-arrhythmic drugs: Insights in animal models. Sci. Rep. 13 (1), 16420 (2023).","journal-title":"Sci. Rep."},{"key":"50392_CR6","doi-asserted-by":"publisher","first-page":"927061","DOI":"10.3389\/fcvm.2022.927061","volume":"9","author":"Y Zheng","year":"2022","unstructured":"Zheng, Y., Xu, L., Dong, N. & Li, F. NLRP3 inflammasome: The rising star in cardiovascular diseases. Front. Cardiovasc. Med. 9, 927061 (2022).","journal-title":"Front. Cardiovasc. Med."},{"issue":"12","key":"50392_CR7","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41419-022-05460-x","volume":"13","author":"Y Bi","year":"2022","unstructured":"Bi, Y. et al. FUNDC1 protects against doxorubicin-induced cardiomyocyte PANoptosis through stabilizing mtDNA via interaction with TUFM. Cell. Death Dis. 13 (12), 1020 (2022).","journal-title":"Cell. Death Dis."},{"key":"50392_CR8","doi-asserted-by":"publisher","first-page":"696362","DOI":"10.3389\/fcvm.2021.696362","volume":"8","author":"Y Wu","year":"2021","unstructured":"Wu, Y. et al. RIP1\/RIP3\/MLKL mediates myocardial function through necroptosis in experimental autoimmune myocarditis. Front. Cardiovasc. Med. 8, 696362 (2021).","journal-title":"Front. Cardiovasc. Med."},{"issue":"5","key":"50392_CR9","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s00018-020-03694-6","volume":"78","author":"H Men","year":"2021","unstructured":"Men, H. et al. The regulatory roles of p53 in cardiovascular health and disease. Cell. Mol. Life Sci. 78 (5), 2001\u20132018 (2021).","journal-title":"Cell. Mol. Life Sci."},{"key":"50392_CR10","doi-asserted-by":"publisher","first-page":"1423622","DOI":"10.3389\/fimmu.2024.1423622","volume":"15","author":"S Li","year":"2024","unstructured":"Li, S. et al. Autoantibody profiling of patients with immune checkpoint inhibitor-associated myocarditis: A pilot study. Front. Immunol. 15, 1423622 (2024).","journal-title":"Front. Immunol."},{"key":"50392_CR11","doi-asserted-by":"publisher","first-page":"1476718","DOI":"10.3389\/fphar.2024.1476718","volume":"15","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. Inhibition of Sat1 alleviates myocardial ischemia-reperfusion injury through regulation of ferroptosis via MAPK\/ERK pathway. Front. Pharmacol. 15, 1476718 (2024).","journal-title":"Front. Pharmacol."},{"key":"50392_CR12","doi-asserted-by":"publisher","first-page":"580170","DOI":"10.2147\/NDT.S580170","volume":"22","author":"C Song","year":"2026","unstructured":"Song, C., Liu, Z., Tang, J. & Huang, Y. Ferroptosis in cerebral ischemia\/reperfusion injury: Mechanistic drivers and therapeutic frontiers. Neuropsychiatr. Dis. Treat. 22, 580170 (2026).","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"11","key":"50392_CR13","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3390\/cimb47110912","volume":"47","author":"Z Du","year":"2025","unstructured":"Du, Z., Huang, F., Liang, Y., Xie, L. & Hu, W. Key components of PPEO in antagonizing cerebral ischemic reperfusion injury in rats by regulating ferroptosis through arachidonic acid metabolic pathway. Curr. Issues Mol. Biol. 47 (11), 912 (2025).","journal-title":"Curr. Issues Mol. Biol."},{"issue":"1","key":"50392_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00011-025-02132-2","volume":"74","author":"V Kondreddy","year":"2025","unstructured":"Kondreddy, V. et al. LPCAT3-dependent remodeling of the phospholipids and lipid rafts is essential for vascular proinflammatory signaling and the development of atherosclerosis. Inflamm. Res. 74 (1), 163 (2025).","journal-title":"Inflamm. Res."},{"key":"50392_CR15","doi-asserted-by":"publisher","first-page":"1541342","DOI":"10.3389\/fgene.2025.1541342","volume":"16","author":"Z Wang","year":"2025","unstructured":"Wang, Z. et al. Bioinformatics analysis and experimental validation of ferroptosis genes in heart failure and atrial fibrillation. Front. Genet. 16, 1541342 (2025).","journal-title":"Front. Genet."},{"issue":"7","key":"50392_CR16","doi-asserted-by":"publisher","first-page":"167912","DOI":"10.1016\/j.bbadis.2025.167912","volume":"1871","author":"W Shaohui","year":"2025","unstructured":"Shaohui, W. et al. STEAP3 alleviates inflammation and fibrosis via iron metabolism in ischemia\/reperfusion-associated lung injury. Biochim. Biophys. Acta Mol. Basis Dis. 1871 (7), 167912 (2025).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"10","key":"50392_CR17","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/humu.22369","volume":"34","author":"G Le Gac","year":"2013","unstructured":"Le Gac, G. et al. Structure-function analysis of the human ferroportin iron exporter (SLC40A1): Effect of hemochromatosis type 4 disease mutations and identification of critical residues. Hum. Mutat. 34 (10), 1371\u20131380 (2013).","journal-title":"Hum. Mutat."},{"issue":"12","key":"50392_CR18","doi-asserted-by":"publisher","first-page":"10159","DOI":"10.3390\/ijms241210159","volume":"24","author":"M Baldan-Martin","year":"2023","unstructured":"Baldan-Martin, M., Chaparro, M. & Gisbert, J. P. Systematic review: Urine biomarker discovery for inflammatory bowel disease diagnosis. Int. J. Mol. Sci. 24 (12), 10159 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"50392_CR19","doi-asserted-by":"publisher","first-page":"e1644","DOI":"10.1002\/wsbm.1644","volume":"16","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. SLC40A1 in iron metabolism, ferroptosis, and disease: A review. WIREs Mech. Dis. 16 (4), e1644 (2024).","journal-title":"WIREs Mech. Dis."},{"issue":"3","key":"50392_CR20","doi-asserted-by":"publisher","first-page":"e70820","DOI":"10.1002\/cns.70820","volume":"32","author":"W Song","year":"2026","unstructured":"Song, W. et al. c-MAF Transcriptionally activates Slc40a1 to repress ferroptosis in sepsis-associated encephalopathy. CNS Neurosci. Ther. 32 (3), e70820 (2026).","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"50392_CR21","doi-asserted-by":"publisher","first-page":"2428147","DOI":"10.1080\/13510002.2024.2428147","volume":"29","author":"Y Fang","year":"2024","unstructured":"Fang, Y. et al. Inhibition of SLC40A1 represses osteoblast formation via inducing iron accumulation and activating the PERK\/ATF4\/CHOP pathway mediated oxidative stress. Redox Rep. 29 (1), 2428147 (2024).","journal-title":"Redox Rep."},{"key":"50392_CR22","doi-asserted-by":"publisher","first-page":"9735555","DOI":"10.1155\/2022\/9735555","volume":"2022","author":"B Huang","year":"2022","unstructured":"Huang, B., Wen, W. & Ye, S. Dapagliflozin ameliorates renal tubular ferroptosis in diabetes via SLC40A1 stabilization. Oxid. Med. Cell. Longev. 2022, 9735555 (2022).","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"50392_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s40001-026-03844-9","volume":"31","author":"G Jin","year":"2026","unstructured":"Jin, G., Zhao, J., Liang, Y. & Yan, X. METTL14 knockdown mitigates HG-induced HK-2 cell apoptosis, inflammation, and ferroptosis by promoting SLC40A1. Eur. J. Med. Res. 31 (1), 305 (2026).","journal-title":"Eur. J. Med. Res."},{"issue":"2","key":"50392_CR24","doi-asserted-by":"publisher","first-page":"414","DOI":"10.7150\/ijbs.89368","volume":"20","author":"R Feng","year":"2024","unstructured":"Feng, R. et al. Elevated SLC40A1 impairs cardiac function and exacerbates mitochondrial dysfunction, oxidative stress, and apoptosis in ischemic myocardia. Int. J. Biol. Sci. 20 (2), 414\u2013432 (2024).","journal-title":"Int. J. Biol. Sci."},{"issue":"14","key":"50392_CR25","doi-asserted-by":"publisher","first-page":"e18543","DOI":"10.1111\/jcmm.18543","volume":"28","author":"JX Song","year":"2024","unstructured":"Song, J. X. et al. Cardiomyocyte-specific overexpression of FPN1 diminishes cardiac hypertrophy induced by chronic intermittent hypoxia. J. Cell. Mol. Med. 28 (14), e18543 (2024).","journal-title":"J. Cell. Mol. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50392-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50392-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50392-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:56:16Z","timestamp":1782172576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50392-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50392"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50392-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19481"}}